Primary Hyperoxaluria Type 1 Latest Advances

Find the Latest Research About Primary Hyperoxaluria Type 1

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 547 publications

Novel AAV843 Vector-Mediated Gene Replacement Therapy Rescues Primary Hyperoxaluria Type I in Mice.

Novel AAV843 Vector-Mediated Gene Replacement Therapy Rescues Primary Hyperoxaluria Type I in Mice.

Journal: Cells

Published: February 13, 2026

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.

Targeting Oxalate Production by Combining Enzyme Inhibition and Proteolysis Activation: A Novel Therapeutic Approach for Primary Hyperoxaluria Type 1.

Journal: Journal of medicinal chemistry

Published: January 02, 2026

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.

The Dawn of Precision Medicine in Pediatric Nephrology: Lumasiran and the Era of siRNA Therapies for Primary Hyperoxaluria Type 1.

Journal: Journal of personalized medicine

Published: November 24, 2025

Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.

Natural History of Advanced Primary Hyperoxaluria Type 1: A Retrospective Study.

Journal: Kidney medicine

Published: November 10, 2025

Genomic testing in pediatric urology: Implications for diagnosis and management.

Genomic testing in pediatric urology: Implications for diagnosis and management.

Journal: Journal of pediatric urology

Published: October 08, 2025

A Case of Successful Kidney Transplant-Alone in Primary Hyperoxaluria Type 1 Using Lumasiran.

A Case of Successful Kidney Transplant-Alone in Primary Hyperoxaluria Type 1 Using Lumasiran.

Journal: Clinical transplantation

Published: September 23, 2025

Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight-Patient Case Series in the Pre-siRNA Era.

Surgical Management of Pediatric Primary Hyperoxaluria Type 1: An Eight-Patient Case Series in the Pre-siRNA Era.

Journal: Pediatric transplantation

Published: September 20, 2025

LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.

LNP-mediated in vivo base editing corrects Agxt to cure primary hyperoxaluria type 1.

Journal: Clinical and translational medicine

Published: July 18, 2025

Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.

Genetic Insights Into Nephrolithiasis and Renal Cancer Predisposition: Precision Medicine in Genes, Diagnosis, and Therapy.

Journal: Seminars in nephrology

Published: July 15, 2025

Impact of Ser81 phosphorylation on alanine: glyoxylate aminotransferase associated with Primary hyperoxaluria type I.

Impact of Ser81 phosphorylation on alanine: glyoxylate aminotransferase associated with Primary hyperoxaluria type I.

Journal: Molecular biomedicine

Published: June 23, 2025

Administration of lumasiran in a child with infantile oxalosis undergoing chronic peritoneal dialysis: A case report

Administration of lumasiran in a child with infantile oxalosis undergoing chronic peritoneal dialysis: A case report

Journal: Nephrologie & therapeutique

Published: June 11, 2025

Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1.

Population Pharmacokinetic and Pharmacodynamic Modelling and Simulation for Nedosiran Clinical Development and Dose Guidance in Pediatric Patients with Primary Hyperoxaluria Type 1.

Journal: Clinical pharmacokinetics

Published: June 05, 2025

Showing 1-12 of 547

Last Updated: 04/28/2026